Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06318286
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-02-27
Brief Title:
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
Sponsor:
Hyogo Medical University
Organization:
Hyogo Medical University
Organization Data
Organization:
Hyogo Medical University
Class:
OTHER
Study ID:
MK3475-IIT-60977
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hyogo Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Prof Kozo Kuribayashi MD PhD
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hyogo Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |